PRPO - Precipio, Inc.

Precipio, Inc.

4 Science Park
New Haven, CT 06511
United States
203-787-7888
http://www.precipiodx.com

Sector: Healthcare
Industry: Diagnostics & Research
Full Time Employees: 42

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Ilan Danieli	Founder, Pres, CEO & Director	263.8k	N/A	1972
Mr. Carl R. Iberger	CFO & Sec.	208.16k	N/A	1953
Mr. Ahmed Zaki Sabet	Chief Operating Officer	163.69k	N/A	1986
Mr. Douglas Sites	VP of Sales	N/A	N/A	N/A
Mr. Ayman Mohamed	Sr. VP of R&D and Laboratory Operations	N/A	N/A	1985

Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients worldwide. It has partnership agreements with the Yale School of Medicine, Dana-Farber Cancer Institute, Inc. and other institutions specializing in cancer research, diagnostics, and treatment; and development agreement with H3 Biomedicine to create a targeted gene panel. The company is based in New Haven, Connecticut.

Corporate Governance

Precipio, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.